Login
$HYPD
$2.99 +$0.14 (4.91%) Close

$HYPD 4/A SEC Filings

Filed On Filing
29 Apr 2025 Form 4/A: Strahlman Ellen R, Director

Received 3,000 shares as a grant or award

29 Apr 2025 Form 4/A: Palanki Ram, Director

Received 3,000 shares as a grant or award

29 Apr 2025 Form 4/A: Mather Charles E Iv, Director

Received 8,000 shares as a grant or award

29 Apr 2025 Form 4/A: Jacobson Rachel, Director

Received 3,000 shares as a grant or award

29 Apr 2025 Form 4/A: Ianchulev Tsontcho, Director

Received 5,000 shares as a grant or award

29 Apr 2025 Form 4/A: Geltzeiler Michael S, Director

Received 5,000 shares as a grant or award

16 May 2023 Form 4/A: Mather Charles E Iv, Director

Bought 4,000 shares ($13.6K)

29 Jun 2022 Form 4/A: Benjamin Stephen Keith, Director

Granted 4,745 Stock Option (right to buy)

29 Jun 2022 Form 4/A: Jacobson Rachel, Director

Granted 4,745 Stock Option (right to buy)

21 Jul 2021 Form 4/A: Clasby Jennifer G, VP, Regulatory and Clinical

Received 24,510 shares by exercise or conversion ($47.8K) · Gave up 13,675 shares to cover exercise price or tax ($74.1K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support